TY - JOUR
T1 - Learning from Post COVID-19 condition for epidemic preparedness
T2 - a variable catalogue for future Post-Acute Infection Syndromes
AU - Górska, A
AU - Canziani, L M
AU - Rinaldi, E
AU - Pana, Z D
AU - Beale, S
AU - Bai, F
AU - Boxma-de Klerk, B M
AU - de Bruijn, S
AU - Donà, D
AU - Ekkelenkamp, M B
AU - Incardona, F
AU - Mallon, P
AU - Marchetti, G C
AU - Puhan, M
AU - Riva, A
AU - Simensen, V C
AU - Vaillant, M
AU - van der Zalm, M M
AU - van Kuijk, S M J
AU - van Wingerden, S
AU - Judd, A
AU - Tacconelli, E
AU - Peñalvo, J L
N1 - Funding:
We acknowledge the support the European Union-funded projects CoMeCT, The Coordination Mechanism for Cohorts and Trials (101136531), ORCHESTRA (101016167), VERDI (101045989), and unCoVer (101016216). Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
Copyright © 2024. Published by Elsevier Ltd.
PY - 2024/12/9
Y1 - 2024/12/9
N2 - SCOPE: The emergence of post-COVID-19 condition (PCC) after SARS-CoV-2 infection underscores the critical need for preparedness in addressing future post-acute infection syndromes (PAIS), particularly those linked to epidemic outbreaks. The lack of standardized clinical and epidemiological data during the COVID-19 pandemic has significantly hindered timely diagnosis and effective treatment of PCC, highlighting the necessity of pre-emptively standardizing data collection in clinical studies to better define and manage future PAIS. In response, the Cohort Coordination Board, a consortium of European-funded COVID-19 research projects, has reviewed data from PCC studies conducted by its members. This paper leverages the Cohort Coordination Board's expertise to propose a standardized catalogue of variables, informed by the lessons learned during the pandemic, intended for immediate use in the design of future observational studies and clinical trials for emerging infections of epidemic potential.RECOMMENDATIONS: The early implementation of standardized data collection, facilitated by the PAIS data catalogue, is essential for accelerating the identification and management of PAIS in future epidemics. This approach will enable more precise syndrome definitions, expedite diagnostic processes, and optimize treatment strategies, while also supporting long-term follow-up of affected individuals. The availability of harmonized data collection protocols will enhance preparedness across European and international cohort studies, and trials enabling a prompt and coordinated response, as well as more efficient resource allocation, in the event of emerging infections and associated PAIS.
AB - SCOPE: The emergence of post-COVID-19 condition (PCC) after SARS-CoV-2 infection underscores the critical need for preparedness in addressing future post-acute infection syndromes (PAIS), particularly those linked to epidemic outbreaks. The lack of standardized clinical and epidemiological data during the COVID-19 pandemic has significantly hindered timely diagnosis and effective treatment of PCC, highlighting the necessity of pre-emptively standardizing data collection in clinical studies to better define and manage future PAIS. In response, the Cohort Coordination Board, a consortium of European-funded COVID-19 research projects, has reviewed data from PCC studies conducted by its members. This paper leverages the Cohort Coordination Board's expertise to propose a standardized catalogue of variables, informed by the lessons learned during the pandemic, intended for immediate use in the design of future observational studies and clinical trials for emerging infections of epidemic potential.RECOMMENDATIONS: The early implementation of standardized data collection, facilitated by the PAIS data catalogue, is essential for accelerating the identification and management of PAIS in future epidemics. This approach will enable more precise syndrome definitions, expedite diagnostic processes, and optimize treatment strategies, while also supporting long-term follow-up of affected individuals. The availability of harmonized data collection protocols will enhance preparedness across European and international cohort studies, and trials enabling a prompt and coordinated response, as well as more efficient resource allocation, in the event of emerging infections and associated PAIS.
UR - https://pubmed.ncbi.nlm.nih.gov/39662824/
U2 - 10.1016/j.cmi.2024.12.001
DO - 10.1016/j.cmi.2024.12.001
M3 - Article
C2 - 39662824
SN - 1198-743X
JO - Clinical Microbiology and Infection
JF - Clinical Microbiology and Infection
ER -